Skip to Main Content

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis


Diseases of the Nervous System

Phase III

What is the purpose of this trial?

The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG).

  • Trial with
    Janssen Research & Development, LLC
  • Start Date
  • End Date

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC